Cystatin C versus Creatinine in Determining Risk Based on Kidney Function
Michael G. Shlipak(San Francisco VA Health Care System), Ron T. Gansevoort(University Medical Center Groningen), Ronit Katz(University of Washington), Andrew S. Levey(Tufts Medical Center), Johan Ärnlöv(Dalarna University), Josef Coresh(New York University), Lesley A. Inker(Tufts Medical Center), Mark J. Sarnak(Tufts Medical Center), Dietrich Rothenbacher(Helmholtz-Institute Ulm), Brad C. Astor(University of Wisconsin–Madison), Kunihiro Matsushita(Johns Hopkins University), Kevan R. Polkinghorne(Monash Health)
Cited by 968
Related Papers
A New Equation to Estimate Glomerular Filtration Rate
|Annals of Internal Medicine|2009|25.7k
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k